The new variant XBB.1.16, a.k.a. Arcturus, has experts concerned it may be linked with the appearance of pink eye, or conjunctivitis, in children.

The new variant XBB.1.16, a.k.a. Arcturus, has experts concerned it may be linked with the appearance of pink eye, or conjunctivitis, in children.

ACARIZAX® is now indicated for treatment of moderate to severe HDM-induced allergic rhinitis, with or without conjunctivitis, in children, adolescents, and adults in Canada aged five to 65.

- ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in children ages 5 through 11 years, in addition to patients 12 through 65 years of ...

Dextenza is not recommended for treating ocular itching with allergic conjunctivitis in children who require sedation for the insertion procedure. The Food and Drug Administration (FDA) has ...

Well, it depends. The advice from NHS England is that: “You don’t need to keep your child away from school if they have conjunctivitis, unless they are feeling very unwell.” But some nurseries and ...

Key Allergic Conjunctivitis Therapies: OK-101, IC-270, VSJ-110, Brimonidine Tartrate, Reproxalap, Ketotifen fumarate ophthalmic solution, Dextenza, and others ...

[1] A survey of allergic conjunctivitis in children in China. Scientific Reports (2022). [2] Development and validation of a health practitioner survey on ocular allergy. Scientific Reports (2024).

ACARIZAX ® is now indicated for treatment of moderate to severe HDM-induced allergic rhinitis, with or without conjunctivitis, in children, adolescents, and adults in Canada aged five to 65. Outside ...